Lava Therapeutics is based in Utrecht, The Netherlands and Philadelphia. It has raised $83M in total funding. Latest round: Series C.
Lava Therapeutics is based in Utrecht, The Netherlands and Philadelphia. Lava Therapeutics has raised $83M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in September 2020. The round record for Lava Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Novo Ventures, Sanofi Ventures, Redmile Group, Ysios Capital, BB Pureos Bioventures, Versant and 2 others. 8 distinct backers are named across the disclosed rounds.
Round data for Lava Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Utrecht and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026